Antus B, Mucsi I, Rosivall L. Apoptosis induction and inhibition of cellular proliferation by angiotensin II: possible Physiologica Hungarica 2000; 87: 5-24.
Valdés F, Pásaro E, Díaz I, et al. Segmental hetero- geneity in Bcl-2, Bcl-xL and Bax expression in rat tubular Nephrology (Carlton) 2008; 13: 294-301.
El Nahas AM. Plasticity of kidney cells: role in kidney remodeling and scarring. Kidney Int 2003; 64: 1553- 1563.
Wang VY, Tzanidis A, Dıvjak M, et al. Altered sig- nalling and regulatory mechanisms of apoptosis in focal and segmental glomerulosclerosis. J Am Soc Nephrol 2001; 12: 1422-1433.
Ruiz-Ortega M, Lorenzo O, Ruperez M, et al. Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension 2001; 38: 1382- 1387.
Ding G, Reddy K, Kapasi AA, et al. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol 2002; 283: 173-180.
Ruilope LM. Renoprotection and renin-anjiotensin sys- tem blockade in diabetes mellitus. Am J Hypertension 1997; 10: 325-331.
Kalender B, Öztürk M, Tunçdemir M, et al. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats. Acta Histochem 2002; 104: 123-130.
Wong VY, Keller PM, Nuttall ME, et al. Role of cas- pases in human renal proximal tubular epithelial cell apoptosis. Eur J Pharm 2001; 433: 135-140.
Ortiz A, Justo P, Sanz A, et al. Targeting apoptosis in acute tubular injury. Biochem Pharmacol 2003; 66: 1589-1594.
Makino H, Sugiyama H, Kashihara N. Apoptosis and extracellular matrix-cell interactions in kidney disease. Kidney Int Suppl 2000; 77: 67-75.
Öztürk M. Editörler: S Yılmazer, M Öztürk. Işık Mikroskopide Uygulamalı Ultrastruktürel İmmunohistokimya Kurs Kitapcığı. İstanbul, 6-8 Mayıs 1998; 48-74.
Tunçdemir M, Özturk M. The effects of ACE inhibitor and angiotensin receptor blocker on clusterin and apoptosis in the kidney tissue of streptozotocin-diabet- ic rats. J Mol Histol 2008; 39: 605-616.
UNISTAT 5.0 (C.T.F. Biyoistatistik) ®)
Bamri-Ezzine S, Ao ZJ, Londono I, et al. Apoptosis of tubular epithelial cells in glycogen nephrosis during diabetes. Lab Invest 2003; 83: 1069-1080.
Zhang G, Khanna P, Chan LL, et al. Diabetes-induced apoptosis in rat kidney. Biochem Mol Med 1997; 61: 58-62.
Kumar D, Zimpelmann J, Robertson S, Burns KD. Tubular and interstitial cell apoptosis in the streptozo- tocin-diabetic rat kidney. Nephron Exp Nephrol 2004; 96: 77-88.
Kelly DJ, Cox AJ, Tolcos M, et al. Attenuation of tubu- lar apoptosis by blockade of the renin-angiotensin sys- tem in diabetic Ren-2 rats. Kidney Int 2002; 61: 31-39.
Ortiz A, Ziyadeh FN, Neilson EG. Expression of apop- tosis-regulatory genes in renal proximal tubular epithe- lial cells exposed to high ambient glucose and in dia- betic kidneys. J Investig Med 1997; 45: 50-56.
Cao Z, Kelly DJ, Cox A, et al. Angiotensin type 2 receptor is expressed in the adult rat kidney and pro- motes cellular proliferation and apoptosis. Kindney Int 2000; 58: 2437-2451.
Zhang G. Role of apoptosis and Bcl-2/Bax in the development of tubulointerstitial fibrozis during exper- imental obstructive nephropathy. Exp Nephrol 2001; 9: 71-80.
Antus B, Mucsi I, Rosivall L. Apoptosis induction and inhibition of cellular proliferation by angiotensin II: possible Physiologica Hungarica 2000; 87: 5-24.
Valdés F, Pásaro E, Díaz I, et al. Segmental hetero- geneity in Bcl-2, Bcl-xL and Bax expression in rat tubular Nephrology (Carlton) 2008; 13: 294-301.
El Nahas AM. Plasticity of kidney cells: role in kidney remodeling and scarring. Kidney Int 2003; 64: 1553- 1563.
Wang VY, Tzanidis A, Dıvjak M, et al. Altered sig- nalling and regulatory mechanisms of apoptosis in focal and segmental glomerulosclerosis. J Am Soc Nephrol 2001; 12: 1422-1433.
Ruiz-Ortega M, Lorenzo O, Ruperez M, et al. Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension 2001; 38: 1382- 1387.
Ding G, Reddy K, Kapasi AA, et al. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol 2002; 283: 173-180.
Ruilope LM. Renoprotection and renin-anjiotensin sys- tem blockade in diabetes mellitus. Am J Hypertension 1997; 10: 325-331.
Kalender B, Öztürk M, Tunçdemir M, et al. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats. Acta Histochem 2002; 104: 123-130.
Wong VY, Keller PM, Nuttall ME, et al. Role of cas- pases in human renal proximal tubular epithelial cell apoptosis. Eur J Pharm 2001; 433: 135-140.
Ortiz A, Justo P, Sanz A, et al. Targeting apoptosis in acute tubular injury. Biochem Pharmacol 2003; 66: 1589-1594.
Makino H, Sugiyama H, Kashihara N. Apoptosis and extracellular matrix-cell interactions in kidney disease. Kidney Int Suppl 2000; 77: 67-75.
Öztürk M. Editörler: S Yılmazer, M Öztürk. Işık Mikroskopide Uygulamalı Ultrastruktürel İmmunohistokimya Kurs Kitapcığı. İstanbul, 6-8 Mayıs 1998; 48-74.
Tunçdemir M, Özturk M. The effects of ACE inhibitor and angiotensin receptor blocker on clusterin and apoptosis in the kidney tissue of streptozotocin-diabet- ic rats. J Mol Histol 2008; 39: 605-616.
UNISTAT 5.0 (C.T.F. Biyoistatistik) ®)
Bamri-Ezzine S, Ao ZJ, Londono I, et al. Apoptosis of tubular epithelial cells in glycogen nephrosis during diabetes. Lab Invest 2003; 83: 1069-1080.
Zhang G, Khanna P, Chan LL, et al. Diabetes-induced apoptosis in rat kidney. Biochem Mol Med 1997; 61: 58-62.
Kumar D, Zimpelmann J, Robertson S, Burns KD. Tubular and interstitial cell apoptosis in the streptozo- tocin-diabetic rat kidney. Nephron Exp Nephrol 2004; 96: 77-88.
Kelly DJ, Cox AJ, Tolcos M, et al. Attenuation of tubu- lar apoptosis by blockade of the renin-angiotensin sys- tem in diabetic Ren-2 rats. Kidney Int 2002; 61: 31-39.
Ortiz A, Ziyadeh FN, Neilson EG. Expression of apop- tosis-regulatory genes in renal proximal tubular epithe- lial cells exposed to high ambient glucose and in dia- betic kidneys. J Investig Med 1997; 45: 50-56.
Cao Z, Kelly DJ, Cox A, et al. Angiotensin type 2 receptor is expressed in the adult rat kidney and pro- motes cellular proliferation and apoptosis. Kindney Int 2000; 58: 2437-2451.
Zhang G. Role of apoptosis and Bcl-2/Bax in the development of tubulointerstitial fibrozis during exper- imental obstructive nephropathy. Exp Nephrol 2001; 9: 71-80.
Tunçdemir, M., & Öztürk, M. (2014). Deneysel Diyabetik Nefropatide İrbesartan’ın Apoptoz Üzerine Koruyucu Etkileri. Cerrahpaşa Tıp Dergisi, 40(1), 15-22.
AMA
Tunçdemir M, Öztürk M. Deneysel Diyabetik Nefropatide İrbesartan’ın Apoptoz Üzerine Koruyucu Etkileri. Cerrahpaşa Tıp Dergisi. Temmuz 2014;40(1):15-22.
Chicago
Tunçdemir, Meltem, ve Melek Öztürk. “Deneysel Diyabetik Nefropatide İrbesartan’ın Apoptoz Üzerine Koruyucu Etkileri”. Cerrahpaşa Tıp Dergisi 40, sy. 1 (Temmuz 2014): 15-22.
EndNote
Tunçdemir M, Öztürk M (01 Temmuz 2014) Deneysel Diyabetik Nefropatide İrbesartan’ın Apoptoz Üzerine Koruyucu Etkileri. Cerrahpaşa Tıp Dergisi 40 1 15–22.
IEEE
M. Tunçdemir ve M. Öztürk, “Deneysel Diyabetik Nefropatide İrbesartan’ın Apoptoz Üzerine Koruyucu Etkileri”, Cerrahpaşa Tıp Dergisi, c. 40, sy. 1, ss. 15–22, 2014.
ISNAD
Tunçdemir, Meltem - Öztürk, Melek. “Deneysel Diyabetik Nefropatide İrbesartan’ın Apoptoz Üzerine Koruyucu Etkileri”. Cerrahpaşa Tıp Dergisi 40/1 (Temmuz 2014), 15-22.
JAMA
Tunçdemir M, Öztürk M. Deneysel Diyabetik Nefropatide İrbesartan’ın Apoptoz Üzerine Koruyucu Etkileri. Cerrahpaşa Tıp Dergisi. 2014;40:15–22.
MLA
Tunçdemir, Meltem ve Melek Öztürk. “Deneysel Diyabetik Nefropatide İrbesartan’ın Apoptoz Üzerine Koruyucu Etkileri”. Cerrahpaşa Tıp Dergisi, c. 40, sy. 1, 2014, ss. 15-22.
Vancouver
Tunçdemir M, Öztürk M. Deneysel Diyabetik Nefropatide İrbesartan’ın Apoptoz Üzerine Koruyucu Etkileri. Cerrahpaşa Tıp Dergisi. 2014;40(1):15-22.